Mount Sterling Clinic — Mount Sterling, Kentucky

Mount Sterling Clinic is a clinical research site located in Mount Sterling, Kentucky, United States 40353.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Mount Sterling Clinic has participated in 2 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus, Overactive Bladder.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mount Sterling

Browse all research sites in Kentucky · View every site in Mount Sterling

• CommonSpirit Saint Joseph Hospital Mount Sterling
• Saint Joseph Mount Sterling
• Montgomery Cancer Center
• Pfizer Investigational Site
• Research Site
• Central Kentucky Research Associates
• Office of Dr. Paul McLaughlin, M.D.
• Paul McLaughlin, MD - Family Practice
• Mt. Sterling Pediatrics
• Investigational Site Number 840048
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sterling Clinic?

Mount Sterling Clinic has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sterling Clinic conducted?

Mount Sterling Clinic has 2 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Overactive Bladder.

Is Mount Sterling Clinic accredited by Crixeo Clinical Trials?

Mount Sterling Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sterling Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.